Scholarlink

<p>In recent years, the dual regulatory role of adipocytes in the tumor microenvironment (TME) has emerged as a critical focus in cancer research. Advances in the fields of metabolic biology and tumor immunology have shown that adipocytes play a crucial role in tumor occurrence, progression, and treatment outcome by secreting adipokines, regulating metabolic reprogramming, and mediating immunosuppressive networks. This article systematically reviews the physiological functions of adipose tissue and its intricate crosstalk with cancer cells, with particular emphasis on dual metabolic and immune mechanisms by which adipocytes dynamically modulate tumor progression within the TME. Furthermore, by integrating preclinical research and translational medicine evidence, a precise treatment framework targeting the interaction between fat and tumor is proposed, providing theoretical basis for the development of metabolic immune combination therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Adipocytes in cancer a metabolic paradox and the dawn of novel therapeutics

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月30日

查看全文
  • Zhuoran Fang,
  • Danni Zhu,
  • Teng Yang,
  • Ruolan Zhang,
  • Qianyu Zhao,
  • Qing Wei,
  • Xiangdong Cheng

摘要

In recent years, the dual regulatory role of adipocytes in the tumor microenvironment (TME) has emerged as a critical focus in cancer research. Advances in the fields of metabolic biology and tumor immunology have shown that adipocytes play a crucial role in tumor occurrence, progression, and treatment outcome by secreting adipokines, regulating metabolic reprogramming, and mediating immunosuppressive networks. This article systematically reviews the physiological functions of adipose tissue and its intricate crosstalk with cancer cells, with particular emphasis on dual metabolic and immune mechanisms by which adipocytes dynamically modulate tumor progression within the TME. Furthermore, by integrating preclinical research and translational medicine evidence, a precise treatment framework targeting the interaction between fat and tumor is proposed, providing theoretical basis for the development of metabolic immune combination therapy.